Analysis of the Immune Microenvironment in Granulomatous Diseases Using Multi-Omics Technologies

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400084922

Enrollment

Unknown

Registered

2024-05-28

Start date

2024-06-01

Completion date

Unknown

Last updated

2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

granulomatous disease and extrapulmonary tuberculosis

Interventions

granulomatous disease:none

Eligibility

Sex/Gender

All

Age

No minimum to 100 Years

Inclusion criteria

Inclusion criteria: Patients presenting with clinical features of granulomas, diagnosed with granulomatous lung disease, or extrapulmonary tuberculosis, or pulmonary tumors and who have undergone biopsy or surgical resection.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
cell subsets identification;	—

Countries

China

Contacts

Public ContactFeng Ding

The Third People's Hospital of Shenzhen

35508421@qq.com+86 136 9174 3821

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026